Covered recipient · General Payments record
LISA KARR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2025
$336.57
- Reported across 15 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.57 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Vanda Pharmaceuticals Inc. | $102.73 | 5 |
| ABBVIE INC. | $94.88 | 4 |
| Axsome Therapeutics, Inc. | $37.30 | 2 |
| Medtronic, Inc. | $35.31 | 1 |
| Lundbeck LLC | $28.70 | 1 |
| Alkermes, Inc. | $20.82 | 1 |
| Kedrion Biopharma, Inc. | $16.83 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $336.57 | 15 |
Payment records · PY2025 (15)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.21 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204502270 | CMS |
| ABBVIE INC. | $24.24 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204502274 | CMS |
| ABBVIE INC. | $17.49 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204502278 | CMS |
| ABBVIE INC. | $32.94 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204502281 | CMS |
| Alkermes, Inc. | $20.82 | 11/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222538029 | CMS |
| Axsome Therapeutics, Inc. | $22.40 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235470416 | CMS |
| Axsome Therapeutics, Inc. | $14.90 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235606631 | CMS |
| Kedrion Biopharma, Inc. | $16.83 | 06/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206769737 | CMS |
| Lundbeck LLC | $28.70 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251920740 | CMS |
| Medtronic, Inc. | $35.31 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219752811 | CMS |
| Vanda Pharmaceuticals Inc. | $16.03 | 06/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233076786 | CMS |
| Vanda Pharmaceuticals Inc. | $17.92 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233076788 | CMS |
| Vanda Pharmaceuticals Inc. | $20.75 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233076790 | CMS |
| Vanda Pharmaceuticals Inc. | $23.57 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233076792 | CMS |
| Vanda Pharmaceuticals Inc. | $24.46 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233076794 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.